Skin Side Effects of Inflammatory Bowel Disease Therapy

Learning the Lessons of Antitumour Necrosis Factor Therapy-Associated Psoriasis

(2016) Matt Shale et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Screening for Skin Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force

(2013) Tracy Wolff   ANNALS OF INTERNAL MEDICINE

Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease

(2012) A. Buisson et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register

(2012) Louise K Mercer et al.   ANNALS OF THE RHEUMATIC DISEASES

Management of Non-Melanoma Skin Cancer in Immunocompromised Solid Organ Transplant Recipients

(2012) Haider K. Bangash et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease

(2012) Millie D. Long et al.   GASTROENTEROLOGY

Infliximab-induced psoriasis during therapy for Crohn's disease

(2012) Flavio Steinwurz et al.   Journal of Crohns & Colitis

Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists

(2012) Elena B. Hawryluk et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature

(2011) G. Cullen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

(2011) X. Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease

(2011) Harminder Singh et al.   GASTROENTEROLOGY

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases

(2011) Iván Guerra et al.   Journal of Crohns & Colitis

Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: A cohort study

(2011) Mashiko Setshedi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer

(2011) Gery P. Guy et al.   PHARMACOECONOMICS

UVA photosensitization of thiopurines and skin cancer in organ transplant recipients

(2011) Natalie R. Attard et al.   PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES

311 nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patients

(2011) Peter Wolf et al.   PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE

Adverse Cutaneous Reactions Induced by TNF-α Antagonist Therapy

(2011) Joaquín Borrás-Blasco et al.   SOUTHERN MEDICAL JOURNAL

Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies

(2010) Natalia Pedersen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case–Control Study

(2010) Richard G Armstrong et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Multiple cutaneous malignancies arising in a patient with Crohn disease treated with concomitant azathioprine and antitumour necrosis factor-α

(2010) A. J. Fogo et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy

(2010) Jean–François Rahier et al.   Clinical Gastroenterology and Hepatology

Multiple and fulminant cutaneous squamous cell carcinomas in a Crohnʼs disease patient treated with immunosuppressants and adalimumab

(2010) S. Nancey et al.   INFLAMMATORY BOWEL DISEASES

Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease

(2010) Florian Beigel et al.   INFLAMMATORY BOWEL DISEASES

Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent

(2010) Sreedhar Subramanian et al.   INFLAMMATORY BOWEL DISEASES

Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: Biological roles and effects of TNF and TNF antagonists

(2010) Yehuda Chowers et al.   Journal of Crohns & Colitis

Dermatopathology of skin cancer in solid organ transplant recipients

(2010) Benjamin Stoff et al.   Transplantation Reviews

Review article: anti TNF-α induced psoriasis in patients with inflammatory bowel disease

(2009) G. FIORINO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Viral DNA detection andRASmutations in actinic keratosis and nonmelanoma skin cancers

(2009) A. Zaravinos et al.   BRITISH JOURNAL OF DERMATOLOGY

Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease

(2009) Millie D. Long et al.   Clinical Gastroenterology and Hepatology

Tailoring the length of antiviral treatment for hepatitis C

(2009) A. Mangia et al.   GUT

Effects of active and passive smoking on disease course of Crohnʼs disease and ulcerative colitis

(2009) Frans van der Heide et al.   INFLAMMATORY BOWEL DISEASES

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

(2009) J.F. Rahier et al.   Journal of Crohns & Colitis

Cutaneous side effects of anti–tumor necrosis factor biologic therapy: A clinical review

(2009) Aikaterini-Evaggelia Moustou et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions

(2009) R. Brem et al.   NUCLEIC ACIDS RESEARCH

Stevens-Johnson syndrome complicating adalimumab therapy in Crohn’s disease

(2009) Muna Salama et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor   therapy: results from the British Society for Rheumatology Biologics Register

(2008) M J Harrison et al.   ANNALS OF THE RHEUMATIC DISEASES

Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases

(2008) Rotraut Mössner et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action

(2008) Angelique N. Collamer et al.   ARTHRITIS AND RHEUMATISM

Clinical pharmacology and pharmacogenetics of thiopurines

(2008) Srikumar Sahasranaman et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases

(2008) Justin M. Ko et al.   JOURNAL OF DERMATOLOGICAL TREATMENT